Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by Human Microbiome Revenue 1.4 Market Analysis by Type 1.4.1 Global Human Microbiome Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 Gastrointestinal Tract Human Micobiome 1.4.3 Urogenital Tract Human Micobiome 1.4.4 Other 1.5 Market by Application 1.5.1 Global Human Microbiome Market Share by Application: 2020 VS 2026 1.5.2 Treatment 1.5.3 Diagnosis 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends by Regions 2.1 Human Microbiome Market Perspective (2015-2026) 2.2 Human Microbiome Growth Trends by Regions 2.2.1 Human Microbiome Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Human Microbiome Historic Market Share by Regions (2015-2020) 2.2.3 Human Microbiome Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 2.3.5 Human Microbiome Market Growth Strategy 2.3.6 Primary Interviews with Key Human Microbiome Players (Opinion Leaders) 3 Competition Landscape by Key Players 3.1 Global Top Human Microbiome Players by Market Size 3.1.1 Global Top Human Microbiome Players by Revenue (2015-2020) 3.1.2 Global Human Microbiome Revenue Market Share by Players (2015-2020) 3.1.3 Global Human Microbiome Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global Human Microbiome Market Concentration Ratio 3.2.1 Global Human Microbiome Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 10 and Top 5 Companies by Human Microbiome Revenue in 2019 3.3 Human Microbiome Key Players Head office and Area Served 3.4 Key Players Human Microbiome Product Solution and Service 3.5 Date of Enter into Human Microbiome Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026) 4.1 Global Human Microbiome Historic Market Size by Type (2015-2020) 4.2 Global Human Microbiome Forecasted Market Size by Type (2021-2026) 5 Human Microbiome Breakdown Data by Application (2015-2026) 5.1 Global Human Microbiome Market Size by Application (2015-2020) 5.2 Global Human Microbiome Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Human Microbiome Market Size (2015-2020) 6.2 Human Microbiome Key Players in North America (2019-2020) 6.3 North America Human Microbiome Market Size by Type (2015-2020) 6.4 North America Human Microbiome Market Size by Application (2015-2020) 7 Europe 7.1 Europe Human Microbiome Market Size (2015-2020) 7.2 Human Microbiome Key Players in Europe (2019-2020) 7.3 Europe Human Microbiome Market Size by Type (2015-2020) 7.4 Europe Human Microbiome Market Size by Application (2015-2020) 8 China 8.1 China Human Microbiome Market Size (2015-2020) 8.2 Human Microbiome Key Players in China (2019-2020) 8.3 China Human Microbiome Market Size by Type (2015-2020) 8.4 China Human Microbiome Market Size by Application (2015-2020) 9 Japan 9.1 Japan Human Microbiome Market Size (2015-2020) 9.2 Human Microbiome Key Players in Japan (2019-2020) 9.3 Japan Human Microbiome Market Size by Type (2015-2020) 9.4 Japan Human Microbiome Market Size by Application (2015-2020) 10 Southeast Asia 10.1 Southeast Asia Human Microbiome Market Size (2015-2020) 10.2 Human Microbiome Key Players in Southeast Asia (2019-2020) 10.3 Southeast Asia Human Microbiome Market Size by Type (2015-2020) 10.4 Southeast Asia Human Microbiome Market Size by Application (2015-2020) 11 India 11.1 India Human Microbiome Market Size (2015-2020) 11.2 Human Microbiome Key Players in India (2019-2020) 11.3 India Human Microbiome Market Size by Type (2015-2020) 11.4 India Human Microbiome Market Size by Application (2015-2020) 12 Central & South America 12.1 Central & South America Human Microbiome Market Size (2015-2020) 12.2 Human Microbiome Key Players in Central & South America (2019-2020) 12.3 Central & South America Human Microbiome Market Size by Type (2015-2020) 12.4 Central & South America Human Microbiome Market Size by Application (2015-2020) 13Key Players Profiles 13.1 Vedanta 13.1.1 Vedanta Company Details 13.1.2 Vedanta Business Overview and Its Total Revenue 13.1.3 Vedanta Human Microbiome Introduction 13.1.4 Vedanta Revenue in Human Microbiome Business (2015-2020)) 13.1.5 Vedanta Recent Development 13.2 Seres Therapeutics 13.2.1 Seres Therapeutics Company Details 13.2.2 Seres Therapeutics Business Overview and Its Total Revenue 13.2.3 Seres Therapeutics Human Microbiome Introduction 13.2.4 Seres Therapeutics Revenue in Human Microbiome Business (2015-2020) 13.2.5 Seres Therapeutics Recent Development 13.3 Second Genome 13.3.1 Second Genome Company Details 13.3.2 Second Genome Business Overview and Its Total Revenue 13.3.3 Second Genome Human Microbiome Introduction 13.3.4 Second Genome Revenue in Human Microbiome Business (2015-2020) 13.3.5 Second Genome Recent Development 13.4 Rebiotix 13.4.1 Rebiotix Company Details 13.4.2 Rebiotix Business Overview and Its Total Revenue 13.4.3 Rebiotix Human Microbiome Introduction 13.4.4 Rebiotix Revenue in Human Microbiome Business (2015-2020) 13.4.5 Rebiotix Recent Development 13.5 ActoGeniX 13.5.1 ActoGeniX Company Details 13.5.2 ActoGeniX Business Overview and Its Total Revenue 13.5.3 ActoGeniX Human Microbiome Introduction 13.5.4 ActoGeniX Revenue in Human Microbiome Business (2015-2020) 13.5.5 ActoGeniX Recent Development 13.6 Enterome BioScience 13.6.1 Enterome BioScience Company Details 13.6.2 Enterome BioScience Business Overview and Its Total Revenue 13.6.3 Enterome BioScience Human Microbiome Introduction 13.6.4 Enterome BioScience Revenue in Human Microbiome Business (2015-2020) 13.6.5 Enterome BioScience Recent Development 13.7 AvidBiotics 13.7.1 AvidBiotics Company Details 13.7.2 AvidBiotics Business Overview and Its Total Revenue 13.7.3 AvidBiotics Human Microbiome Introduction 13.7.4 AvidBiotics Revenue in Human Microbiome Business (2015-2020) 13.7.5 AvidBiotics Recent Development 13.8 4D Pharma Research Ltd 13.8.1 4D Pharma Research Ltd Company Details 13.8.2 4D Pharma Research Ltd Business Overview and Its Total Revenue 13.8.3 4D Pharma Research Ltd Human Microbiome Introduction 13.8.4 4D Pharma Research Ltd Revenue in Human Microbiome Business (2015-2020) 13.8.5 4D Pharma Research Ltd Recent Development 13.9 Enterologics 13.9.1 Enterologics Company Details 13.9.2 Enterologics Business Overview and Its Total Revenue 13.9.3 Enterologics Human Microbiome Introduction 13.9.4 Enterologics Revenue in Human Microbiome Business (2015-2020) 13.9.5 Enterologics Recent Development 13.10 Metabogen 13.10.1 Metabogen Company Details 13.10.2 Metabogen Business Overview and Its Total Revenue 13.10.3 Metabogen Human Microbiome Introduction 13.10.4 Metabogen Revenue in Human Microbiome Business (2015-2020) 13.10.5 Metabogen Recent Development 13.11 Metabiomics 10.11.1 Metabiomics Company Details 10.11.2 Metabiomics Business Overview and Its Total Revenue 10.11.3 Metabiomics Human Microbiome Introduction 10.11.4 Metabiomics Revenue in Human Microbiome Business (2015-2020) 10.11.5 Metabiomics Recent Development 13.12 Ritter Pharmaceuticals 10.12.1 Ritter Pharmaceuticals Company Details 10.12.2 Ritter Pharmaceuticals Business Overview and Its Total Revenue 10.12.3 Ritter Pharmaceuticals Human Microbiome Introduction 10.12.4 Ritter Pharmaceuticals Revenue in Human Microbiome Business (2015-2020) 10.12.5 Ritter Pharmaceuticals Recent Development 13.13 Osel 10.13.1 Osel Company Details 10.13.2 Osel Business Overview and Its Total Revenue 10.13.3 Osel Human Microbiome Introduction 10.13.4 Osel Revenue in Human Microbiome Business (2015-2020) 10.13.5 Osel Recent Development 13.14 Symberix 10.14.1 Symberix Company Details 10.14.2 Symberix Business Overview and Its Total Revenue 10.14.3 Symberix Human Microbiome Introduction 10.14.4 Symberix Revenue in Human Microbiome Business (2015-2020) 10.14.5 Symberix Recent Development 13.15 Miomics 10.15.1 Miomics Company Details 10.15.2 Miomics Business Overview and Its Total Revenue 10.15.3 Miomics Human Microbiome Introduction 10.15.4 Miomics Revenue in Human Microbiome Business (2015-2020) 10.15.5 Miomics Recent Development 13.16 Symbiotix Biotherapies 10.16.1 Symbiotix Biotherapies Company Details 10.16.2 Symbiotix Biotherapies Business Overview and Its Total Revenue 10.16.3 Symbiotix Biotherapies Human Microbiome Introduction 10.16.4 Symbiotix Biotherapies Revenue in Human Microbiome Business (2015-2020) 10.16.5 Symbiotix Biotherapies Recent Development 13.17 MicroBiome Therapeutics LLC 10.17.1 MicroBiome Therapeutics LLC Company Details 10.17.2 MicroBiome Therapeutics LLC Business Overview and Its Total Revenue 10.17.3 MicroBiome Therapeutics LLC Human Microbiome Introduction 10.17.4 MicroBiome Therapeutics LLC Revenue in Human Microbiome Business (2015-2020) 10.17.5 MicroBiome Therapeutics LLC Recent Development 14Analyst's Viewpoints/Conclusions 15Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Disclaimer 15.3 Author Details

List of Tables Table 1. Human Microbiome Key Market Segments Table 2. Key Players Covered: Ranking by Human Microbiome Revenue Table 3. Ranking of Global Top Human Microbiome Manufacturers by Revenue (US$ Million) in 2019 Table 4. Global Human Microbiome Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 5. Key Players of Gastrointestinal Tract Human Micobiome Table 6. Key Players of Urogenital Tract Human Micobiome Table 7. Key Players of Other Table 8. Global Human Microbiome Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 9. Global Human Microbiome Market Size by Regions (US$ Million): 2020 VS 2026 Table 10. Global Human Microbiome Market Size by Regions (2015-2020) (US$ Million) Table 11. Global Human Microbiome Market Share by Regions (2015-2020) Table 12. Global Human Microbiome Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 13. Global Human Microbiome Market Share by Regions (2021-2026) Table 14. Market Top Trends Table 15. Key Drivers: Impact Analysis Table 16. Key Challenges Table 17. Human Microbiome Market Growth Strategy Table 18. Main Points Interviewed from Key Human Microbiome Players Table 19. Global Human Microbiome Revenue by Players (2015-2020) (Million US$) Table 20. Global Human Microbiome Market Share by Players (2015-2020) Table 21. Global Top Human Microbiome Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Microbiome as of 2019) Table 22. Global Human Microbiome by Players Market Concentration Ratio (CR5 and HHI) Table 23. Key Players Headquarters and Area Served Table 24. Key Players Human Microbiome Product Solution and Service Table 25. Date of Enter into Human Microbiome Market Table 26. Mergers & Acquisitions, Expansion Plans Table 27. Global Human Microbiome Market Size by Type (2015-2020) (Million US$) Table 28. Global Human Microbiome Market Size Share by Type (2015-2020) Table 29. Global Human Microbiome Revenue Market Share by Type (2021-2026) Table 30. Global Human Microbiome Market Size Share by Application (2015-2020) Table 31. Global Human Microbiome Market Size by Application (2015-2020) (Million US$) Table 32. Global Human Microbiome Market Size Share by Application (2021-2026) Table 33. North America Key Players Human Microbiome Revenue (2019-2020) (Million US$) Table 34. North America Key Players Human Microbiome Market Share (2019-2020) Table 35. North America Human Microbiome Market Size by Type (2015-2020) (Million US$) Table 36. North America Human Microbiome Market Share by Type (2015-2020) Table 37. North America Human Microbiome Market Size by Application (2015-2020) (Million US$) Table 38. North America Human Microbiome Market Share by Application (2015-2020) Table 39. Europe Key Players Human Microbiome Revenue (2019-2020) (Million US$) Table 40. Europe Key Players Human Microbiome Market Share (2019-2020) Table 41. Europe Human Microbiome Market Size by Type (2015-2020) (Million US$) Table 42. Europe Human Microbiome Market Share by Type (2015-2020) Table 43. Europe Human Microbiome Market Size by Application (2015-2020) (Million US$) Table 44. Europe Human Microbiome Market Share by Application (2015-2020) Table 45. China Key Players Human Microbiome Revenue (2019-2020) (Million US$) Table 46. China Key Players Human Microbiome Market Share (2019-2020) Table 47. China Human Microbiome Market Size by Type (2015-2020) (Million US$) Table 48. China Human Microbiome Market Share by Type (2015-2020) Table 49. China Human Microbiome Market Size by Application (2015-2020) (Million US$) Table 50. China Human Microbiome Market Share by Application (2015-2020) Table 51. Japan Key Players Human Microbiome Revenue (2019-2020) (Million US$) Table 52. Japan Key Players Human Microbiome Market Share (2019-2020) Table 53. Japan Human Microbiome Market Size by Type (2015-2020) (Million US$) Table 54. Japan Human Microbiome Market Share by Type (2015-2020) Table 55. Japan Human Microbiome Market Size by Application (2015-2020) (Million US$) Table 56. Japan Human Microbiome Market Share by Application (2015-2020) Table 57. Southeast Asia Key Players Human Microbiome Revenue (2019-2020) (Million US$) Table 58. Southeast Asia Key Players Human Microbiome Market Share (2019-2020) Table 59. Southeast Asia Human Microbiome Market Size by Type (2015-2020) (Million US$) Table 60. Southeast Asia Human Microbiome Market Share by Type (2015-2020) Table 61. Southeast Asia Human Microbiome Market Size by Application (2015-2020) (Million US$) Table 62. Southeast Asia Human Microbiome Market Share by Application (2015-2020) Table 63. India Key Players Human Microbiome Revenue (2019-2020) (Million US$) Table 64. India Key Players Human Microbiome Market Share (2019-2020) Table 65. India Human Microbiome Market Size by Type (2015-2020) (Million US$) Table 66. India Human Microbiome Market Share by Type (2015-2020) Table 67. India Human Microbiome Market Size by Application (2015-2020) (Million US$) Table 68. India Human Microbiome Market Share by Application (2015-2020) Table 69. Central & South America Key Players Human Microbiome Revenue (2019-2020) (Million US$) Table 70. Central & South America Key Players Human Microbiome Market Share (2019-2020) Table 71. Central & South America Human Microbiome Market Size by Type (2015-2020) (Million US$) Table 72. Central & South America Human Microbiome Market Share by Type (2015-2020) Table 73. Central & South America Human Microbiome Market Size by Application (2015-2020) (Million US$) Table 74. Central & South America Human Microbiome Market Share by Application (2015-2020) Table 75. Vedanta Company Details Table 76. Vedanta Business Overview Table 77. Vedanta Product Table 78. Vedanta Revenue in Human Microbiome Business (2015-2020) (Million US$) Table 79. Vedanta Recent Development Table 80. Seres Therapeutics Company Details Table 81. Seres Therapeutics Business Overview Table 82. Seres Therapeutics Product Table 83. Seres Therapeutics Revenue in Human Microbiome Business (2015-2020) (Million US$) Table 84. Seres Therapeutics Recent Development Table 85. Second Genome Company Details Table 86. Second Genome Business Overview Table 87. Second Genome Product Table 88. Second Genome Revenue in Human Microbiome Business (2015-2020) (Million US$) Table 89. Second Genome Recent Development Table 90. Rebiotix Company Details Table 91. Rebiotix Business Overview Table 92. Rebiotix Product Table 93. Rebiotix Revenue in Human Microbiome Business (2015-2020) (Million US$) Table 94. Rebiotix Recent Development Table 95. ActoGeniX Company Details Table 96. ActoGeniX Business Overview Table 97. ActoGeniX Product Table 98. ActoGeniX Revenue in Human Microbiome Business (2015-2020) (Million US$) Table 99. ActoGeniX Recent Development Table 100. Enterome BioScience Company Details Table 101. Enterome BioScience Business Overview Table 102. Enterome BioScience Product Table 103. Enterome BioScience Revenue in Human Microbiome Business (2015-2020) (Million US$) Table 104. Enterome BioScience Recent Development Table 105. AvidBiotics Company Details Table 106. AvidBiotics Business Overview Table 107. AvidBiotics Product Table 108. AvidBiotics Revenue in Human Microbiome Business (2015-2020) (Million US$) Table 109. AvidBiotics Recent Development Table 110. 4D Pharma Research Ltd Business Overview Table 111. 4D Pharma Research Ltd Product Table 112. 4D Pharma Research Ltd Company Details Table 113. 4D Pharma Research Ltd Revenue in Human Microbiome Business (2015-2020) (Million US$) Table 114. 4D Pharma Research Ltd Recent Development Table 115. Enterologics Company Details Table 116. Enterologics Business Overview Table 117. Enterologics Product Table 118. Enterologics Revenue in Human Microbiome Business (2015-2020) (Million US$) Table 119. Enterologics Recent Development Table 120. Metabogen Company Details Table 121. Metabogen Business Overview Table 122. Metabogen Product Table 123. Metabogen Revenue in Human Microbiome Business (2015-2020) (Million US$) Table 124. Metabogen Recent Development Table 125. Metabiomics Company Details Table 126. Metabiomics Business Overview Table 127. Metabiomics Product Table 128. Metabiomics Revenue in Human Microbiome Business (2015-2020) (Million US$) Table 129. Metabiomics Recent Development Table 130. Ritter Pharmaceuticals Company Details Table 131. Ritter Pharmaceuticals Business Overview Table 132. Ritter Pharmaceuticals Product Table 133. Ritter Pharmaceuticals Revenue in Human Microbiome Business (2015-2020) (Million US$) Table 134. Ritter Pharmaceuticals Recent Development Table 135. Osel Company Details Table 136. Osel Business Overview Table 137. Osel Product Table 138. Osel Revenue in Human Microbiome Business (2015-2020) (Million US$) Table 139. Osel Recent Development Table 140. Symberix Company Details Table 141. Symberix Business Overview Table 142. Symberix Product Table 143. Symberix Revenue in Human Microbiome Business (2015-2020) (Million US$) Table 144. Symberix Recent Development Table 145. Miomics Company Details Table 146. Miomics Business Overview Table 147. Miomics Product Table 148. Miomics Revenue in Human Microbiome Business (2015-2020) (Million US$) Table 149. Miomics Recent Development Table 150. Symbiotix Biotherapies Company Details Table 151. Symbiotix Biotherapies Business Overview Table 152. Symbiotix Biotherapies Product Table 153. Symbiotix Biotherapies Revenue in Human Microbiome Business (2015-2020) (Million US$) Table 154. Symbiotix Biotherapies Recent Development Table 155. MicroBiome Therapeutics LLC Company Details Table 156. MicroBiome Therapeutics LLC Business Overview Table 157. MicroBiome Therapeutics LLC Product Table 158. MicroBiome Therapeutics LLC Revenue in Human Microbiome Business (2015-2020) (Million US$) Table 159. MicroBiome Therapeutics LLC Recent Development Table 160. Research Programs/Design for This Report Table 161. Key Data Information from Secondary Sources Table 162. Key Data Information from Primary Sources List of Figures Figure 1. Global Human Microbiome Market Share by Type: 2020 VS 2026 Figure 2. Gastrointestinal Tract Human Micobiome Features Figure 3. Urogenital Tract Human Micobiome Features Figure 4. Other Features Figure 5. Global Human Microbiome Market Share by Application: 2020 VS 2026 Figure 6. Treatment Case Studies Figure 7. Diagnosis Case Studies Figure 8. Human Microbiome Report Years Considered Figure 9. Global Human Microbiome Market Size YoY Growth 2015-2026 (US$ Million) Figure 10. Global Human Microbiome Market Share by Regions: 2020 VS 2026 Figure 11. Global Human Microbiome Market Share by Regions (2021-2026) Figure 12. Porter's Five Forces Analysis Figure 13. Global Human Microbiome Market Share by Players in 2019 Figure 14. Global Top Human Microbiome Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Microbiome as of 2019 Figure 15. The Top 10 and 5 Players Market Share by Human Microbiome Revenue in 2019 Figure 16. North America Human Microbiome Market Size YoY Growth (2015-2020) (Million US$) Figure 17. Europe Human Microbiome Market Size YoY Growth (2015-2020) (Million US$) Figure 18. China Human Microbiome Market Size YoY Growth (2015-2020) (Million US$) Figure 19. Japan Human Microbiome Market Size YoY Growth (2015-2020) (Million US$) Figure 20. Southeast Asia Human Microbiome Market Size YoY Growth (2015-2020) (Million US$) Figure 21. India Human Microbiome Market Size YoY Growth (2015-2020) (Million US$) Figure 22. Central & South America Human Microbiome Market Size YoY Growth (2015-2020) (Million US$) Figure 23. Vedanta Total Revenue (US$ Million): 2019 Compared with 2018 Figure 24. Vedanta Revenue Growth Rate in Human Microbiome Business (2015-2020) Figure 25. Seres Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018 Figure 26. Seres Therapeutics Revenue Growth Rate in Human Microbiome Business (2015-2020) Figure 27. Second Genome Total Revenue (US$ Million): 2019 Compared with 2018 Figure 28. Second Genome Revenue Growth Rate in Human Microbiome Business (2015-2020) Figure 29. Rebiotix Total Revenue (US$ Million): 2019 Compared with 2018 Figure 30. Rebiotix Revenue Growth Rate in Human Microbiome Business (2015-2020) Figure 31. ActoGeniX Total Revenue (US$ Million): 2019 Compared with 2018 Figure 32. ActoGeniX Revenue Growth Rate in Human Microbiome Business (2015-2020) Figure 33. Enterome BioScience Total Revenue (US$ Million): 2019 Compared with 2018 Figure 34. Enterome BioScience Revenue Growth Rate in Human Microbiome Business (2015-2020) Figure 35. AvidBiotics Total Revenue (US$ Million): 2019 Compared with 2018 Figure 36. AvidBiotics Revenue Growth Rate in Human Microbiome Business (2015-2020) Figure 37. 4D Pharma Research Ltd Total Revenue (US$ Million): 2019 Compared with 2018 Figure 38. 4D Pharma Research Ltd Revenue Growth Rate in Human Microbiome Business (2015-2020) Figure 39. Enterologics Total Revenue (US$ Million): 2019 Compared with 2018 Figure 40. Enterologics Revenue Growth Rate in Human Microbiome Business (2015-2020) Figure 41. Metabogen Total Revenue (US$ Million): 2019 Compared with 2018 Figure 42. Metabogen Revenue Growth Rate in Human Microbiome Business (2015-2020) Figure 43. Metabiomics Total Revenue (US$ Million): 2019 Compared with 2018 Figure 44. Metabiomics Revenue Growth Rate in Human Microbiome Business (2015-2020) Figure 45. Ritter Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018 Figure 46. Ritter Pharmaceuticals Revenue Growth Rate in Human Microbiome Business (2015-2020) Figure 47. Osel Total Revenue (US$ Million): 2019 Compared with 2018 Figure 48. Osel Revenue Growth Rate in Human Microbiome Business (2015-2020) Figure 49. Symberix Total Revenue (US$ Million): 2019 Compared with 2018 Figure 50. Symberix Revenue Growth Rate in Human Microbiome Business (2015-2020) Figure 51. Miomics Total Revenue (US$ Million): 2019 Compared with 2018 Figure 52. Miomics Revenue Growth Rate in Human Microbiome Business (2015-2020) Figure 53. Symbiotix Biotherapies Total Revenue (US$ Million): 2019 Compared with 2018 Figure 54. Symbiotix Biotherapies Revenue Growth Rate in Human Microbiome Business (2015-2020) Figure 55. MicroBiome Therapeutics LLC Total Revenue (US$ Million): 2019 Compared with 2018 Figure 56. MicroBiome Therapeutics LLC Revenue Growth Rate in Human Microbiome Business (2015-2020) Figure 57. Bottom-up and Top-down Approaches for This Report Figure 58. Data Triangulation Figure 59. Key Executives Interviewed

Vedanta Seres Therapeutics Second Genome Rebiotix ActoGeniX Enterome BioScience AvidBiotics 4D Pharma Research Ltd Enterologics Metabogen Metabiomics Ritter Pharmaceuticals Osel Symberix Miomics Symbiotix Biotherapies MicroBiome Therapeutics LLC